Díaz Pinzón, Jorge Enrique
BMJ. Enfermedad por coronavirus 2019 (COVID-19). [Internet]. 2020 [ Citado el 13 de enero de 2021]. Recuperado de: https://bestpractice.bmj.com/topics/es-es/3000201 2. Zhou P, ZL. SARS-CoV-2 spillover events. Science. 2021;371(6525):120-122. doi:10.1126/science.abf6097 3. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020;382(13):1199-1207. doi:10.1056/NEJMoa2001316 4. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu, Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. doi:10.1016/S0140-6736(20)30566-3 5. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. J Emerg Med. 2020;58(4): 711–712. doi:10.1016/j.jemermed.2020.04.004 6. Fauci, AS, Lane HC, Redfield RR. Covid-19 - Navigating the Uncharte....  , 2022

Díaz Pinzón, Jorge Enrique
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020;382(13):1199-1207. doi:10.1056/NEJMoa2001316 2. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu, Z. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. doi:10.1016/S0140-6736(20)30566-3 3. Hoffmann, M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271-280.e8. doi:10.1016/j.cell.2020.02.052 4. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323(16):1574-1581. doi:10.1001/jama.2020.5394 5. Docherty A, Harrison E, Verde C, Hardw....  , 2022

Díaz Pinzón, Jorge Enrique
BMJ Best Practice. Enfermedad por coronavirus 2019 (COVID-19) [Internet]. 2020 [Citado el 13 de enero de 2021]; Disponible en: https://bestpractice.bmj.com/topics/es-es/3000201 2. Zhou P, Li Shi Z. SARS-CoV-2 spillover events. Science. 2021;371(6525):120-122. doi:10.1126/science.abf6097 3. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020;382(13):1199-1207. doi:10.1056/NEJMoa2001316 4. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. doi:10.1016/S0140-6736(20)30566-3 5. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Zhong NS, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720. doi:10.1056/NEJMoa2002032 6. Fauci AS, Lane CH, Redfield RR. Covid-19 - Navigati....  , 2022